Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2007.11.9685PMID 17906203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

  2007cited by this paper
• Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921.

  2007cited by this paper
• Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer

  2006cited by this paper
• Chemotherapy with preoperative radiotherapy in rectal cancer.

  2006cited by this paper
• Postoperative Chemotherapy May Not Be Necessary for Patients With ypN0-Category After Neoadjuvant Chemoradiotherapy of Rectal Cancer

  2006cited by this paper
• Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

  2006cited by this paper
• Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

  2006cited by this paper
• Prognostic markers of local relapse in rectal cancer: are we any further forward?

  2006cited by this paper
• Low rectal cancer: a call for a change of approach in abdominoperineal resection.

  2005cited by this paper
• Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

  2005cited by this paper
• Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

  2005cited by this paper
• Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

  2004cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Bmc Medical Research Methodology Open Access a Perfect Correlate Does Not a Surrogate Make

  2003cited by this paper
• Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

  2002cited by this paper
• Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer

  2001cited by this paper
• Sample size requirements and length of study for testing interaction in a 1 × k factorial design when time-to-failure is the outcome

  1993cited by this paper
• Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected].

  1993cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Hyperthermia-targeted rectal delivery of thermosensitive liposomal doxorubicin via intra-arterial and intravenous administration.

  2026cites this paper
• Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancer

  2025cites this paper
• Survival benefit and impact of adjuvant chemotherapy following neoadjuvant therapy in patients with locally advanced rectal cancer

  2025cites this paper
• New Frontiers in the Treatment of Rectal Cancer.

  2025cites this paper
• Acetone compression improves lymph node yield and metastasis detection in colorectal cancer

  2024cites this paper
• Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response

  2024influential citation
• The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.

  2024cites this paper
• Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer

  2024cites this paper
• Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?

  2024cites this paper
• Could elective nodal irradiation for locally advanced rectal cancer be omitted in the context of total neoadjuvant therapy? An analysis of the recurrence sites of rectal cancer

  2024cites this paper
• Some is Better than None: Adjuvant Chemotherapy in Rectal Cancer After Pathologic Complete Response

  2024cites this paper
• The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy

  2024cites this paper
• Prognostic Significance of Desmoplastic Reaction After Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer

  2024cites this paper
• Can yStage Ⅰ/Ⅱ rectal cancer patients be treated in the same way as stage Ⅰ/Ⅱ patients?

  2024cites this paper
• New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy

  2024cites this paper
• Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy

  2023cites this paper
• The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis

  2023cites this paper
• Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review

  2023cites this paper
• Total neoadjuvant therapy in rectal cancer: a network meta-analysis of randomized trials

  2023cites this paper
• Intratumoral Budding and CD8-Positive T-cell Density in Pretreatment Biopsies as a Predictor of Response to Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer.

  2023cites this paper
• microRNAs combined to radiomic features as a predictor of complete clinical response after neoadjuvant radio-chemotherapy for locally advanced rectal cancer: a preliminary study

  2023cites this paper
• Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision

  2022cites this paper
• Safety of the total neo-adjuvant therapy in rectal cancer treatment. Preliminary results of the randomized trial

  2022cites this paper
• Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

  2022cites this paper
• Comment on Timing of Surgery For Patients With Rectal Cancers Not Responding to Preoperative Chemoradiation.

  2022cites this paper
• Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study

  2022cites this paper
• Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection

  2022cites this paper
• Management of Rectal Cancer.

  2022cites this paper
• Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study.

  2022cites this paper
• Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study

  2022cites this paper
• 18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer

  2022cites this paper
• Locally Advanced Rectal Cancer: What We Learned in the Last Two Decades and the Future Perspectives

  2022cites this paper
• Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?

  2022cites this paper
• Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis

  2022cites this paper
• Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation

  2021cites this paper
• Geriatrische gastrointestinale Onkologie: Ösophagus, Magen, Dickdarm

  2021cites this paper
• Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation

  2021cites this paper
• Current evidence regarding the role of adjuvant chemotherapy in rectal cancer patients with pathologic complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

  2021cites this paper
• High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients

  2021cites this paper
• Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer

  2021cites this paper
• Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto

  2021cites this paper
• Stratified Prognostic Value of Pathological Response to Preoperative Treatment in yp II/III Rectal Cancer

  2021cites this paper
• Preoperative vs postoperative radiotherapy in the management of rectal cancer: A systematic review

  2021cites this paper
• Radiomics-Based Preoperative Prediction of Lymph Node Status Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer

  2020cites this paper
• Survival Benefit for Metformin Through Better Tumor Response By Neoadjuvant CCRT in Rectal Cancer.

  2020cites this paper
• Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives.

  2020cites this paper
• Comprehensive review of targeted therapy for colorectal cancer

  2020cites this paper
• Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives.

  2020cites this paper
• Neoadjuvant Treatment in Pancreatic Cancer

  2020cites this paper
• Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients

  2020cites this paper
• The Novel CFP Scoring System is a Reliable Marker in Predicting Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

  2020cites this paper
• Optimizing the treatment sequence for localized pancreatic cancer

  2020cites this paper
• Multidisciplinary Treatment of Rectal Cancer

  2020cites this paper
• Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG).

  2020cites this paper
• Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection

  2020cites this paper
• Locally Advanced Rectal Cancer

  2020cites this paper
• Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy

  2020cites this paper
• Rectal Cancer: Assessing Response to Neoadjuvant Therapy.

  2020cites this paper
• Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data

  2020cites this paper
• Circulating tumor DNA in colorectal cancer: opportunities and challenges.

  2020cites this paper
• Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

  2020cites this paper
• Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study

  2020cites this paper
• Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort

  2020cites this paper
• Prognostic significance of lymph node yield in patients with synchronous colorectal carcinomas

  2020cites this paper
• Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

  2020cites this paper
• Oncologic effects of adjuvant chemotherapy in patients with ypT0–2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis

  2020cites this paper
• CMAR_A_273065 8555..8568

  2020cites this paper
• Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer

  2020cites this paper
• Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence

  2020cites this paper
• Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review

  2020cites this paper
• Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy

  2020cites this paper
• Gastrointestinal Cancers

  2019cites this paper
• Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy

  2019cites this paper
• Colorectal Cancer: Postoperative Adjuvant Therapy

  2019cites this paper
• Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

  2019cites this paper
• Recomendaciones para diagnóstico y tratamiento del cáncer de colon y recto en México

  2019cites this paper
• Rectal cancer and chemoradiation in Iraq: systematic review and meta-analysis

  2019cites this paper
• The clinical significance of simple endoscopic scoring of patients with rectal cancer after concurrent chemoradiotherapy.

  2019cites this paper
• Absolute Clinical Radiation Oncology Review

  2019cites this paper
• Adjuvant chemotherapy in rectal cancer patients who achieved a pathological complete response after preoperative chemoradiotherapy: a systematic review and meta-analysis

  2019cites this paper
• Emerging trends in the treatment of rectal cancer

  2019cites this paper
• Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery

  2019cites this paper
• The Changing Face of Abdominoperineal Excision

  2019cites this paper
• Radiation Therapy: The North American Approach

  2019cites this paper
• Total neoadjuvant therapy for rectal cancer

  2019cites this paper
• Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response

  2019cites this paper
• Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.

  2019cites this paper
• Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response.

  2019cites this paper
• The Swedish Approach Towards Radiotherapy and Rectal Cancer: Making Sense of Where They Have Been and Where They Are Going

  2019cites this paper
• Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials

  2018cites this paper
• Pseudoadjuvant chemotherapy in resectable metastatic colorectal cancer

  2018cites this paper
• Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified

  2018cites this paper
• Prognostic Value of the Cycle Number of Perioperative Chemotherapy in Locoregionally Advanced Rectal Cancer: a Propensity Score Matching Analysis

  2018cites this paper
• Impact of Neoadjuvant Chemo Radiation in Carcinoma Rectum: A Tertiary Care Institute Experience

  2018cites this paper
• Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis

  2018cites this paper
• Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection

  2018cites this paper
• Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis

  2018cites this paper
• Meta-analysis of the influence of time interval between radical operation and preoperative chemoradiotherapy on complete pathological response in rectal cancer patients

  2018cites this paper
• Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System

  2018cites this paper
• Adjuvant chemotherapy may improve disease-free survival in patients with persistently mrEMVI-positive rectal cancer following chemoradiation

  2018cites this paper